We examined the expression of AIM2 in 114 pairs of colorectal cancers versus paracancerous using immunohistochemistry and showed that AIM2 was significantly low expressed in colorectal cancers (Figures 5A, B, P=0.026). Here, AIM2 is linked to colorectal cancer.